SEC 13F Intelligence

Newport Trust Company, LLC / ELV

Newport Trust Company, LLC’s Elevance Health Inc Formerly Position

Does Newport Trust Company, LLC own Elevance Health Inc Formerly (ELV)? Yes985.2K shares worth $288M (+0.71% of its 13F portfolio) as of Q1 2026, down from 1.01M shares the prior filed quarter.

Position Value
$288M
Q1 2026
Shares
985.2K
% of Portfolio
+0.71%
Quarters Held
22
currently held

Position History ELV

Reported value by quarter
Q4 ’20: $472MQ4 ’20Q1 ’21: $513MQ2 ’21: $533MQ3 ’21: $513MQ3 ’21Q4 ’21: $629MQ1 ’22: $660MQ2 ’22: $640MQ2 ’22Q3 ’22: $593MQ4 ’22: $662MQ1 ’23: $589MQ1 ’23Q2 ’23: $561MQ3 ’23: $541MQ4 ’23: $571MQ4 ’23Q1 ’24: $611MQ2 ’24: $621MQ3 ’24: $587MQ3 ’24Q4 ’24: $408MQ1 ’25: $464MQ2 ’25: $407MQ2 ’25Q3 ’25: $331MQ4 ’25: $352MQ1 ’26: $288MQ1 ’26filingsflow.com
QuarterSharesValue% of Portfolio
Q1 2026985.2K$288M+0.71%
Q4 20251.01M$352M+0.84%
Q3 20251.02M$331M+0.75%
Q2 20251.05M$407M+0.98%
Q1 20251.07M$464M+1.19%
Q4 20241.11M$408M+0.99%
Q3 20241.13M$587M+1.42%
Q2 20241.15M$621M+1.56%
Q1 20241.18M$611M+1.66%
Q4 20231.21M$571M+1.52%
Q3 20231.24M$541M+1.66%
Q2 20231.26M$561M+1.64%
Q1 20231.28M$589M+1.63%
Q4 20221.29M$662M+1.84%
Q3 20221.31M$593M+2.01%
Q2 20221.33M$640M+2.07%
Q1 20221.34M$660M+1.85%
Q4 20211.36M$629M+1.70%
Q3 20211.37M$513M+1.39%
Q2 20211.40M$533M+1.35%
Q1 20211.43M$513M+1.28%
Q4 20201.47M$472M+1.30%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Newport Trust Company, LLC’s full portfolio or all institutional holders of ELV.